It was also found that β-arrestin acts as an ETAR signal transducer by inactivating GSK-3β through the PI3K/ILK/AKT pathway, thereby promoting WNT signaling and contributing to the chemoresistance, invasion, and metastasis of ovarian tumors. Here, ILK is linked to ovarian neoplasm.